Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lonza Biologics Tuas

2007 FOUNDED
PRIVATE STATUS
M&A LATEST DEAL TYPE
Description

Provider of a medical research and development services intended to offer large-scale cell culture manufacturing facilities. The company's medical research and development services offers a site for the production of monoclonal antibodies and recombinant proteins, enabling its clients to receive treatment related to large-scale cell culture.

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 35 Tuas South Avenue 6
  • Singapore, 637377
  • Singapore

+65 6521 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lonza Biologics Tuas’s full profile, request a free trial.

Lonza Biologics Tuas Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Jan-2008 Completed Generating Revenue
2. Early Stage VC Completed Generating Revenue
1. Joint Venture 01-Jan-2007 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Lonza Biologics Tuas Board Members (1)

Name Representing Role Since Contact
Info
Stephan Kutzer Ph.D Self Chairman 000 0000